护理点（POC）诊断市场份额，规模，趋势，行业分析报告，平台（侧向流动测定，减少仪，微流体，分子诊断，免疫测定）;通过最终用途（诊所，医院，家庭，辅助生活医疗保健设施，实验室）;乐动娱乐官网通过产品;按地区;分部预测，2020 - 2027年

Report Summary

The global Point of Care (PoC) diagnostics market was valued at USD 18.37 billion in 2019 and is expected to grow at a CAGR of 3.3% during the forecast period. The key factors responsible for the Point of Care (PoC) diagnostics industry growth include a surge in infectious diseases in the past decade, rising prevalence of target diseases such as diabetes, blood-related disorders, and other lifestyle borne diseases, growing need of patients on real-time diagnosis supported with the technological advancements, and significance of home healthcare treatment as a viable option for geriatrics across the globe.

According to the International Diabetes Federation (IDF), the number of people suffering from diabetes was 415 million in 2015, which is expected to reach approximately 640 million by 2040. Moreover, the recent data estimated by CDC show that nearly 29 million Americans have diabetes and one out of four are not aware of their condition. However, product recalls and time-consuming approval processes are limiting market growth. Moreover, the patient’s reluctance in shifting from traditional methods to Point of Care (PoC) diagnostics systems also hindering its growth prospects.

Know more about this report:请求样本页面

行业动态

成长司机
健身应用的出现和智能手机的升高已经开辟了下一代护理点（POC）诊断的门，越来越减少了周转时间，创造了对护理点（POC）设备的需求。一个这样的例子包括附着毛细管微流体芯片的智能手机应用，该芯片用于患有心肌梗死的人的心肌肌钙蛋白I的快速诊断测试。该测试适用于资源约束医疗机构，在12分钟内提供结果。乐动娱乐官网

最近的进步扩大了这些护理点（POC）诊断系统的能力。通过扩展的测试菜单，这些设备可以向医生或审查员提供患者的医疗记录的实时结果以进行审查。此类系统还更新了更新的功能，旨在帮助医院适当地管理任务。

新兴国家的急诊室和政府运营的医院总是面临过度挤，这导致等待时间，延迟治疗，延长患者患者，患者不满。大多数此类ED都是用胸痛，发热，正常病毒感染和腹痛的特异性重复查询，消耗宝贵的时间。如果使用此类护理点（POC）诊断设备的流程流策划，则可能有一些空闲时间留下医生。这些举措将增加患者流动并缩短患者留下。

护理点（POC）诊断市场报告范围

该市场主要基于产品，平台，最终用途和地理区域进行分段。

By Product	通过平台	通过最终使用	按地区
Glucose Testing HB1AC测试 凝血 Fertility Infectious Diseases 艾滋病病毒 Clostridium艰难术 HBV. 肺炎或链球菌相关的感染 呼吸合胞病毒（RSV） HPV. Influenza/Flu HCV. MRSA. TB和耐药TB HSV. 其他 心脏标记 甲状腺刺激激素 血液学 初级保健系统 分散的临床化学 Feces 脂质测试 癌症标记 血液气体/电解质 守护化学 药物滥用测试 Urinalysis	侧向流动测定 Dipsticks 微流体 Molecular Diagnostics Immunoassays	诊所 医生办公室 药房和零售诊所 非练习诊所 紧急护理诊所 Hospitals 家 Assisted Living Healthcare Facilities Laboratory	北美（美国，加拿大） Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太（日本，中国，印度，马来西亚，印度尼西亚，韩国） 拉丁美洲(巴西、墨西哥、基于“增大化现实”技术gentina) 中东和非洲（沙特阿拉伯，阿联酋，以色列，南非）

Know more about this report:请求样本页面

产品洞察力

2019年，葡萄糖测试点（POC）诊断市场部门在全球市场中获得了大部分份额。这种高份额归因于全球糖尿病和相关疾病的上升案例。根据IDF的估计，2019年，大约4.63亿令人患糖尿病患者和相同的数字预计将达到7亿左右，到2045年。糖尿病诊断的技术进步对于实时诊断也有利于Point of Care (PoC) diagnostics market segment’s growth.

The rising popularity of wearable/portable glucose meters, owing to their speed, user-friendliness, and less operational cost also stimulated uptake of such products. Emerging collaborations among market players to favor product penetration also favored Point of Care (PoC) diagnostics industry segment growth. For instance, in August 2019, Xylonix and BioGemex introduced a pre-treatment Point of Care (PoC) diagnostic testing method for the detection of immunotherapy reactions in patients having solid tumors. This test useful for old age people who require home care self-sufficient medical assistance. Such product introductions into the Point of Care (PoC) diagnostics industry are projected to have a growth trajectory over the forecast period.

最终用途的洞察

Based on the end-use, the clinics segment accounted for the largest revenue share. In 2019, the rise in the establishment of Point of Care (PoC) diagnostics laboratory centers in clinics is responsible for the segment’s high revenue share. Such dedicated centers enhance patient-centered medical care, with reduced healthcare costs, which results in the decentralization of healthcare, and the improved patient outcome. There is an increasing trend to outsource testing procedures by hospitals. This has increased test efficiency and lower labor costs. Moreover, favorable policies of Medicare and the CHIP Reauthorization Act also favored the Point of Care (PoC) diagnostics industry segment’s growth prospects.

家庭分部目睹了研究期内最快的增长率。预测对这种利润丰厚的增长负责的因素是儿科和老年人口中的护理点（POC）测试的上升。发展中国家的出生率下降以及获得医疗保健的进入寿命增加，糖尿病，记忆力丧失和生活方式相关的心脏病等少数共生命条件增加了预期寿命。

地理概述

地理上，全球护理点（POC）诊断行业分叉进入北美，欧洲，亚太地区，拉丁美洲和中东和非洲（MEA）。北美地区是欧洲和亚太地区的最大收入贡献者。2019年，北美地区占全球市场的40％以上。

该地区的增长归因于关键参与者，支持政府赞助的研究机构，如美国心脏协会，国际糖尿病联合会，美国糖尿病协会，以及其他敬业的学术机构。此外，技术的小型化也在塑造未来方面发挥了至关重要的作用。例如，2019年10月，Fujifilm SonoSite引入了该国医生的超声系统（PoC）超声系统。

Asia Pacific Point of Care (PoC) diagnostics industry is projected to register the highest growth rate over the study period. This future growth is due to concerted efforts of the local and international players to reach the untapped emerging country, with a huge patient pool. For instance, in January 2020, Mindray Medical introduced the TE7 ACE Point of Care (PoC) ultrasound system for emergency and critical care situations.

Competitive Insight

The prominent players operating in the Point of Care (PoC) diagnostics industry are Roche Diagnostics, EKF Diagnostics, Siemens Healthineers, Chembio Diagnostic Systems, Johnson & Johnson, Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Quidel Corporation, Nova Biomedical, PTS Diagnostics, Trinity Biotech, AccuBioTech, Instrumentation Laboratory Company, and Sekisui Diagnostics.